SCHEMBL19970830

SCHEMBL19970830

O=C(Nc1ccc(C(F)(F)F)cc1)N1CCN(Cc2ccc3nc(-c4cccnc4)[nH]c3c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 6/20 0.56
SLC2A1 P11166 2/20 0.53
HIF1A Q16665 1/20 0.53
EPAS1 Q99814 1/20 0.53
PRKAB2 O43741 3/20 0.51
PRKAG1 P54619 3/20 0.51
PRKAA2 P54646 3/20 0.51
PRKAA1 Q13131 3/20 0.51
PRKAG3 Q9UGI9 3/20 0.51
PRKAG2 Q9UGJ0 3/20 0.51
PRKAB1 Q9Y478 3/20 0.51
TRPV1 Q8NER1 1/20 0.51
ALDH1A1 P00352 3/20 0.50
HPGD P15428 2/20 0.50
DGAT1 O75907 1/20 0.50
KCNH2 Q12809 1/20 0.50
HSD17B10 Q99714 1/20 0.50
AURKA O14965 1/20 0.49
CDK1 P06493 1/20 0.49
CCNB1 P14635 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19970829 0.94 FAAH (0.56) FAAHSLC2A1HIF1AEPAS1PRKAB2
SCHEMBL19970728 0.91 FAAH (0.63) FAAHSLC2A1HIF1AEPAS1PRKAB2
SCHEMBL19970868 0.90 ALDH1A1 (0.55) FAAHALDH1A1HPGDDGAT1HSD17B10
SCHEMBL19970798 0.87 KCNH2 (0.62) SLC2A1HIF1AEPAS1ALDH1A1HPGD
SCHEMBL19970862 0.85 FAAH (0.57) FAAHSLC2A1PRKAB2PRKAG1PRKAA2
SCHEMBL19970737 0.85 SLC2A1 (0.57) SLC2A1HIF1AEPAS1PRKAB2PRKAG1
SCHEMBL19970727 0.84 FAAH (0.63) FAAHSLC2A1HIF1AEPAS1PRKAB2
SCHEMBL19970867 0.83 FAAH (0.54) FAAHALDH1A1HPGDDGAT1HSD17B10
SCHEMBL19970797 0.80 DGAT1 (0.53) SLC2A1HIF1AEPAS1ALDH1A1HPGD
SCHEMBL19986738 0.80 SLC2A1 (0.46) FAAHSLC2A1ALDH1A1HPGDDGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11479571-B2 Benzimidazol derivatives for treating filovirus infection CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2022-10-25 US disclosed
US-20210292350-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION UNIVERSITE D'ORLEANS (FR) 2021-09-23 US disclosed
US-20210292350-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION UNIVERSITE D'ORLEANS (FR) 2021-09-23 US disclosed
WO-2018050771-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-03-22 WO disclosed
EP-3296297-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-03-21 EP disclosed
EP-3296297-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292350-A1 BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION FIP1L1, ZC3HAV1, MAVS FAAH 3154/4885SLC2A1 4852/4885HIF1A 3621/4885
US-11479571-B2 Benzimidazol derivatives for treating filovirus infection FIP1L1, ZC3HAV1, MAVS FAAH 3154/4885SLC2A1 4852/4885HIF1A 3621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.